Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|May 29, 2019
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple SclerosisIris Lavon, Coral Heli, Livnat Brill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2010
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white populationAdi Vaknin-Dembinsky, Livnat Brill, Naama Orpaz, et al.
Journal of Neuroimmunology|May 4, 2024
A protective effect of lower MHC-II expression in MOGADAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of the Neurological Sciences|January 19, 2024
Thyroid hormone dysfunction in MOGAD and other demyelinating diseasesAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|August 24, 2015
Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levelsKarin Mausner-Fainberg, Keren Regev, Hadar Kolb, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2021
Brain MRI activity during the year before pregnancy can predict post-partum clinical relapsesHillel Lehmann, Omri Zveik, Netta Levin, et al.
Journal of Neuroimmunology|April 2, 2008
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSAdi Vaknin-Dembinsky, Steven D Brass, Steven Brass, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Journal of Neuroimmunology|July 10, 2022
IL-6 as a marker for NMOSD disease activityAdi Haramati, Ariel Rechtman, Omri Zveik, et al.
Journal of Neuroimmunology|April 12, 2008
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosisAdi Vaknin-Dembinsky, Gopal Murugaiyan, David A Hafler, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|May 29, 2019
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple SclerosisIris Lavon, Coral Heli, Livnat Brill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2010
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white populationAdi Vaknin-Dembinsky, Livnat Brill, Naama Orpaz, et al.
Journal of Neuroimmunology|May 4, 2024
A protective effect of lower MHC-II expression in MOGADAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of the Neurological Sciences|January 19, 2024
Thyroid hormone dysfunction in MOGAD and other demyelinating diseasesAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|August 24, 2015
Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levelsKarin Mausner-Fainberg, Keren Regev, Hadar Kolb, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2021
Brain MRI activity during the year before pregnancy can predict post-partum clinical relapsesHillel Lehmann, Omri Zveik, Netta Levin, et al.
Journal of Neuroimmunology|April 2, 2008
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MSAdi Vaknin-Dembinsky, Steven D Brass, Steven Brass, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Journal of Neuroimmunology|July 10, 2022
IL-6 as a marker for NMOSD disease activityAdi Haramati, Ariel Rechtman, Omri Zveik, et al.
Journal of Neuroimmunology|April 12, 2008
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosisAdi Vaknin-Dembinsky, Gopal Murugaiyan, David A Hafler, et al.
Pageof 9